Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature.
about
A systematic review of the prevalence of schizophrenia.The long journey to a Systems Biology of neuronal functionHelping to prioritise interventions for depression and schizophrenia: use of Population Impact MeasuresAn evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature reviewThe global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013A bibliometric study of scientific research conducted on second-generation antipsychotic drugs in SingaporeCognition, function, and disability in patients with schizophrenia: a review of longitudinal studiesPrevalence of complications in neuromuscular scoliosis surgery: a literature meta-analysis from the past 15 yearsCurious cases: Acromegaly and schizophrenia: an incidental association?Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration databaseEvolutionary conservation in genes underlying human psychiatric disordersOlfactory discrimination varies in mice with different levels of α7-nicotinic acetylcholine receptor expressionAutonomic function in hypertension; role of genetic variation at the catecholamine storage vesicle protein chromogranin BThe MATISSE study: a randomised trial of group art therapy for people with schizophreniaEssential fatty acids and psychiatric disorders.A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophreniaPrevalence and incidence studies of mood disorders: a systematic review of the literature.A prospective study of health care resource utilisation and selected costs of schizophrenia in France.Paliperidone: the evidence of its therapeutic value in schizophrenia.Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada.Time-lapse mapping of cortical changes in schizophrenia with different treatmentsNutrition and schizophrenia: an epidemiological and clinical perspective.Polymorphism of the CLDN5 gene and Schizophrenia in an Iranian Population.Prevalence of psychotic disorders in an urban area of France.DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophreniaValidation of a Population-Based Algorithm to Detect Chronic Psychotic Illness.Absence of bias in clinician ratings of everyday functioning among African American, Hispanic and Caucasian patients with schizophreniaIs early intervention for psychosis feasible and effective?Epidemiology and Treatment Guidelines of Negative Symptoms in Schizo-phrenia in Central and Eastern Europe: A Literature Review.Productivity loss and resource utilization, and associated indirect and direct costs in individuals providing care for adults with schizophrenia in the EU5.Reducing emergency medical service use in patients with chronic psychotic disorders: results from the FAST intervention study.Evaluating the clinical and cost effectiveness of a behaviour change intervention for lowering cardiovascular disease risk for people with severe mental illnesses in primary care (PRIMROSE study): study protocol for a cluster randomised controlled tRelation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections?Money matters: does the reimbursement policy for second generation antipsychotics influence the number of recorded schizophrenia patients and the burden of stigmatization?Risperidone long-acting injection in the treatment of schizophrenia spectrum illnesses: A retrospective chart review of 19 patients in the Vancouver Community Mental Health Organization (Vancouver, Canada)Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophreniaSchizophrenia: medical illness, mortality, and aging.Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin.Lifetime Prevalence and Correlates of Schizophrenia-Spectrum, Affective, and Other Non-affective Psychotic Disorders in the Chinese Adult Population.Extreme population differences across Neuregulin 1 gene, with implications for association studies.
P2860
Q21144720-2A35F19B-9370-48F3-A47E-8EF583646C41Q21202798-4B0BF66E-4266-4410-BDAC-322CC6C7C3D1Q24547993-1EA51D8E-623C-4A0F-A286-ADEFC2B7FAD8Q26799270-C220137A-1BF5-4488-BE6A-4D1E5442D956Q26827666-1AF25E11-0A78-4801-BBBA-D23F7708CC29Q26994688-D451EC67-E096-4799-9B77-C61FE17A09E5Q27006837-07BF08AC-8A49-46B5-81EA-E1903D823648Q27011838-4D6F97FA-865C-484E-82C0-7DD4C10406D4Q27025160-A4FE905F-C897-4C97-AB35-EDC4E0BAD959Q28481584-79133BE5-E9AF-4AB5-9526-AA4FE4D26EADQ28657468-13239C74-BDE4-410D-A289-E76BBE156D22Q30473395-AAE00965-4738-4165-9B55-9AEC0D4323EBQ30492306-E6CA14EE-DFD4-4D63-8FC9-318D6AD04C41Q30988171-5D5B84E5-86CE-4F61-9D68-22AB5A9BFB7CQ34202271-F52C5CB9-500D-4BC2-8709-709847B7B6B3Q34203368-22A86304-125D-4AF0-9C1A-97C249F2068BQ34311167-EA230418-4044-4417-85AF-65F07760F039Q34386873-DA26761B-0D1F-4735-ADF9-86E30F0500D7Q34449894-1812483F-913C-445A-B436-F7A7EFA4B583Q34746791-3A878DE0-1542-4F55-9D9B-75FF12F103E1Q35015837-8D639C4F-574A-46F8-A257-03D89E7A2FCBQ35619516-0896F99B-0348-4F67-8884-3F793F5741E1Q35678868-13F30E23-8A43-4041-AFD6-862933ABBD74Q35753980-86569E9B-2ECD-4E36-B13A-811D1D43BF88Q35779904-CE3E7449-F4E8-46C9-A518-92D76FEFD875Q35974142-4B41C7C3-CB50-4639-93D5-AE7C56C5E7C8Q35988529-B8780CAF-BB76-4466-8750-5AEB5464887FQ36201294-6B8D8B5A-F99F-4F11-9235-ECC64D73F021Q36232324-0E9C1E5F-BD85-41E8-B6BF-E1D1416F72A2Q36332188-5888C2A3-6D62-4032-9D63-AAA5DFAA4490Q36473665-2F5C20C0-22D7-4197-9D96-27CAB3A7FFBAQ36574892-35ED6287-6BB9-4B08-93F5-42E6B3559529Q37159635-41043B39-BE29-4F30-8CE7-C461E6D26E17Q37672466-F1CB4EAD-857E-429E-81FD-6B4B7DE82BD6Q37672702-2A54DF02-2E61-4600-A564-71A145F90DA1Q37698891-E11B81C9-EB07-4582-A1B2-CAB10CFFBEC7Q37954653-D61510BC-C764-4CA9-958A-F7DDFD7728EEQ38403090-CED24886-B977-472E-A20D-7813C0D537D9Q38740775-F09E9916-BBD1-4CE1-867F-D2BF4737DDAAQ40385572-598448E3-8533-445F-9C3F-6462C6A607C4
P2860
Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prevalence and incidence studi ...... atic review of the literature.
@ast
Prevalence and incidence studi ...... atic review of the literature.
@en
Prevalence and incidence studi ...... atic review of the literature.
@nl
type
label
Prevalence and incidence studi ...... atic review of the literature.
@ast
Prevalence and incidence studi ...... atic review of the literature.
@en
Prevalence and incidence studi ...... atic review of the literature.
@nl
prefLabel
Prevalence and incidence studi ...... atic review of the literature.
@ast
Prevalence and incidence studi ...... atic review of the literature.
@en
Prevalence and incidence studi ...... atic review of the literature.
@nl
P2093
P2860
P1476
Prevalence and incidence studi ...... atic review of the literature.
@en
P2093
Elliot M Goldner
Julian M Somers
Lorena Hsu
Paul Waraich
P2860
P304
P356
10.1177/070674370204700904
P407
P577
2002-11-01T00:00:00Z